Condition: Autoimmune Diseases · Sponsor: Fresenius Medical Care Deutschland GmbH
Analysis of therapeutic plasma exchange (TPE) treatments to assess the performance of the TPE mode of multiFiltratePRO based on the successful exchange of plasma from whole blood. The multiFiltratePRO is a device for extracorporeal blood purification treatments.
This description comes directly from the study's public registry record.
Manuela Stauss-Grabo, Dr. · +4915254601929 · Manuela.Stauss-Grabo1@freseniusmedicalcare.com
Anna Wammi · +49 6172 2686700 · anna.wammi@freseniusmedicalcare.com
Always discuss trial participation with your own doctor first.
| Klinikum Aschaffenburg-Alzenau | Aschaffenburg, Bavaria, Germany | Recruiting |
| Universitätsklinikum Würzburg | Würzburg, Bavaria, Germany | Recruiting |
| Charité-Universitätsmedizin Berlin | Berlin, State of Berlin, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06272084